<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00678522</url>
  </required_header>
  <id_info>
    <org_study_id>MED.RES.HOS.2006.04.LP</org_study_id>
    <nct_id>NCT00678522</nct_id>
  </id_info>
  <brief_title>The Acute Effect of Atorvastain on Renal Function in Patients With Type II Diabetes</brief_title>
  <official_title>The Acute Effect of Atorvastatin on Renal Sodium Excretion, Glomerular Filtration Rate, Tubular Function and Vasoactive Hormones in Patients With Non-Insulin Dependent Type II Diabetes.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Regional Hospital Holstebro</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medical Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Regional Hospital Holstebro</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      We wanted to test the hypothesis that acute treatment with atorvastatin changes renal sodium
      excretion, glomerular filtration rate, tubular function and vasoactive hormones in patients
      with type II diabetes, not in treatment with insulin.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2007</start_date>
  <completion_date type="Actual">May 2008</completion_date>
  <primary_completion_date type="Actual">May 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>GFR, clearance of sodium and lithium, fractional excretion of sodium and lithium, U-AQP-2, total sodium excretion, albumin excretion rate and free water clearance.</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>AVP, Ang-II, Aldo, ANP, BNP, PRC, BP, HR.</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Healthy Subjects</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Atorvastatin</intervention_name>
    <description>80 mg atorvastatin daily on two following days</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age: 40-70 yrs

          2. estimated GFR between 30 and 90 ml/min

          3. BMI&lt;35

          4. Fertile women had to use oral contraceptives or IUD

          5. HbA1c&lt; 10%

          6. Urine-albumin&lt;1,5 g/l

        Exclusion Criteria:

          1. Treatment with insulin

          2. Cerobrovascular insult or other disease of the brain

          3. Insufficiency of the heart or lungs

          4. Liverdisease with ALAT &gt; 200 U/L

          5. hemoglobin &lt; 7,0 mmol/l

          6. Cancer

          7. Alcohol abuse

          8. Medical treatment with psycopharmaca or/and analgetics

          9. Pregnancy and breast feeding, 10 blood donation one month before the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Erling B. Pedersen, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept. of medical reaserch, Holstebro Hospital, Denmark</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical Reseach, Holstebro Hospital</name>
      <address>
        <city>Holstebro</city>
        <zip>5500</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Medical Research, Holstebro Hospital</name>
      <address>
        <city>Holstebro</city>
        <zip>7500</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>May 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 13, 2008</study_first_submitted>
  <study_first_submitted_qc>May 14, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 15, 2008</study_first_posted>
  <last_update_submitted>May 14, 2008</last_update_submitted>
  <last_update_submitted_qc>May 14, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 15, 2008</last_update_posted>
  <responsible_party>
    <name_title>Lone Paulsen</name_title>
    <organization>Medical Research</organization>
  </responsible_party>
  <keyword>Atorvastatin</keyword>
  <keyword>Renal function</keyword>
  <keyword>Hemodynamics</keyword>
  <keyword>Diabetes type II</keyword>
  <keyword>sodium excretion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atorvastatin Calcium</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

